Nakamoto Inc. Common Stock (NAKA) is a publicly traded Healthcare sector company. As of May 21, 2026, NAKA trades at $0.16 with a market cap of $118.33M and a P/E ratio of -0.61. NAKA moved -6.15% today. Year to date, NAKA is -68.90%; over the trailing twelve months it is flat. Its 52-week range spans $0.15 to $29.50. Analyst consensus is strong buy with an average price target of $0.75. Rallies surfaces NAKA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nakamoto Q4 Revenue Drops 26% to $444,924, Repurchases 2.33M Shares: Nakamoto reported Q4 2025 revenue of $444,924 compared with $603,887 a year earlier and completed repurchase of 2,332,206 shares to bolster shareholder value. Since August 2025, the company acquired BTC Inc and UTXO Management in February 2026 and initiated exit of its legacy healthcare operations to streamline costs.
| Metric | Value |
|---|---|
| Price | $0.16 |
| Market Cap | $118.33M |
| P/E Ratio | -0.61 |
| EPS | $-0.26 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.50 |
| 52-Week Low | $0.15 |
| Volume | 82.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.82M |
| Net Income | $-52.23M |
| Gross Margin | 0.00% |
3 analysts cover NAKA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $0.75.